Badrinath R Konety MD

Minimally Invasive Surgery, Surgical Oncology

President, Allina Health Cancer Institute

Summary

Dr. Badrinath Konety is a urologist based in Minneapolis, MN, with subspecialties in minimally invasive surgery and surgical oncology. He completed his medical education at Bangalore Medical College in 1990 and underwent residencies in surgery and urology at UPMC Medical Education. He is experienced in procedures such as cystectomy, prostatectomy, urologic oncology, and lymph node excision. Dr. Konety has contributed to several publications, including studies on prostate cancer treatment and bladder cancer therapy, with his work on intravesical nadofaragene receiving notable citations. He has participated in clinical trials on prostate cancer and cystectomy techniques. His accolades include being recognized as a Regional Top Doctor by Castle Connolly and achieving CMS Meaningful Use Stage 1 Certification.

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

PubMed

Development and psychometric evaluation of a patient-reported symptom index for patients with non-muscle invasive bladder cancer: the NMIBC-SI.
Claudia Rutherford, Margaret-Ann Tait, Daniel S J Costa, Madeleine T King, David P Smith
Journal of Patient-Reported Outcomes. 2025-03-27
Safety of nadofaragene firadenovec-vncg: review of data from phase 2 and phase 3 studies.
Badrinath R Konety, Yair Lotan, Amanda Myers
The Canadian Journal of Urology. 2025-03-18
Synergistic RAS-MAPK and AKT Activation in MYC-Driven Tumors via Adjacent PVT1 Rearrangements.
Ashutosh Tiwari, Utkarsha Paithane, Jordan Friedlein, Kojiro Tashiro, Olivier Saulnier
Biorxiv. 2025-02-22

Journal Articles

A Clinical Prediction Tool to Determine the Need for Concurrent Systematic Sampling at the Time of MRI‐Guided Biopsy
Benjamin Spilseth, Badrinath R Konety, Maria A Ordonez, Christopher J Weight, Christopher A Warlick, Paari Murugan, BJU International
Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists
Christopher J Weight, Stephen B Williams, James B Yu, Jon C Tilburt, Simon P Kim, Badrinath Konety, Annals of Surgical Oncology
Landmarks in Prostate Cancer
Badrinath Konety, MD, Nature
BMI1 Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is a Potential Therapeutic Target: Hypothesis Tested in Race-Specific Models
Badrinath R Konety, Paari Murugan, Clinical Cancer Research
Join now to see all

How Allina Doctors Are Deploying AI to Double-Check Cancer ScreeningsApril 10th, 2025
Allina Health Launches Cancer Mobile AppMay 20th, 2024
Optimizing BCG Therapy in Bladder Cancer: Expert Insights on Managing Toxicity and Maximizing Efficacy - Badrinath Konety & Wassim KassoufMay 12th, 2023
Join now to see all